Onkologie. 2016:10(4):175-180 | DOI: 10.36290/xon.2016.038

Controversial issues in breast cancer radiotherapy

Iveta Kolářová, Jaroslav Vaňásek
Komplexní onkologické centrum Pardubického kraje, Multiscan, s. r. o.

Treatment of breast cancer consists of a multidisciplinary approach that involves surgery, radiation oncology, and medical

oncology. Radiation therapy is a fundamental part of breast cancer treatment. The objective of adjuvant radiation therapy is

to eradicate any tumor deposits remaining following surgery for patients treated by either breast-conserving surgery or mastectomy.

This therapy improves overall survivals, and also decreases risk of locoregional recurrence. The work is focused on

current findings of breast cancer radiotherapy after total mastectomy as well as breast-conserving surgery, and controversial

trends such as the accelerated partial breast irradiation and the alternative fractionation models, as well as the new topics of

nodal areas radiotherapy.

Keywords: radiotherapy, breast cancer, accelerated partial irradiation, brachytherapy, alternative fractionation

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolářová I, Vaňásek J. Controversial issues in breast cancer radiotherapy. Onkologie. 2016;10(4):175-180. doi: 10.36290/xon.2016.038.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087. Go to original source... Go to PubMed...
    2. Nielsen HM, Overgaard M, et al. Danish Breast Cancer Cooperative Group Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006; 24: 2268. Go to original source... Go to PubMed...
    3. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 949. Go to original source...
    4. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641. Go to original source...
    5. Wang J, Shi M, Ling R, et al. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial. Radiother Oncol 2011; 100: 200. Go to original source...
    6. McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Lancet 2014; 383: 2127. Go to original source...
    7. Huo D, Hou N, Jaskowiak N, et al. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol 2015; 22: 4295. Go to original source...
    8. Liu J, Mao K, Jiang S, et al. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB. Oncotarget 2015. Go to original source...
    9. McGuire SE, Gonzalez-Angulo AM, Huang EH, et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1004. Go to original source...
    10. Mamounas EP, Anderson SJ, Dignam JJ, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 2012; 30: 3960. Go to original source... Go to PubMed...
    11. De Los Santos, JF. Adjuvant Radiation Therapy for Women with Newly Diagnosed, Non-metastatic Breast Cancer. UpToDate. May 10, 2016. Dostupný z: https://www.uptodate.com/contents/adjuvant-radiation-therapy-for-women-with-newly-diagnosed-non-metastatic-breast-cancer?source=search_result&search=Adjuvant+radiation+therapy+for+women+with+newly+diagnosed%2C+non-metastatic+breast+cancer&selectedTitle=1~150.
    12. Jagsi R. Progress and controversies: radiation therapy for invasive breast cancer. CA Cancer J Clin. 2014 Mar-Apr;64(2):135-52. doi: 10.3322/caac.21209. Epub 2013 Dec. Go to original source...
    13. Fisher B, Anderson S, Bryant J, et al. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med. 2002; 347: 1233-1241. Go to original source...
    14. Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Lancet. 2011; 378: 1707-1716. Go to original source...
    15. Lim M, Bello J, Gelman R, et al. A prospective study of conservative surgery without radiation therapy in select patients with stage I breast cancer. Int J Radiat Oncol Biol Phys. 2006; 65: 1149-1154. Go to original source...
    16. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004; 351: 963-970. Go to original source...
    17. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013; 31: 2382-2387. Go to original source...
    18. Kunkler IH, Williams LJ, Jack WJ, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 2015; 16: 266. Go to original source...
    19. Bartelink H, Maingon P, Poortmans P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 2015; 16: 47. Go to original source...
    20. van Asselen B, Schwarz M, van Vliet-Vroegindeweij C, et al. Intensity-modulated radiotherapy of breast cancer using direct aperture optimization. Radiother Oncol. 2006; 79: 162-169. Go to original source...
    21. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Joint Annual Meeting of the Canadian Association of Radiation Oncology/Canadian Organization of Medical Physicists. Toronto, Canada, 2007. J Clin Oncol. 2008; 26: 2085-2092. Go to original source... Go to PubMed...
    22. Wolmark N, Curran WJ, Vicini F, et al. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010; 76: 71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" (Int J Radiat Oncol Biol Phys 2009;75:1290-1296) [letter]. Int J Radiat Oncol Biol Phys. 2010; 77: 317. Go to original source...
    23. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362: 513-520. Go to original source...
    24. James ML, Lehman M, Hider PN, et al. Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev 2010; CD003860. Go to original source...
    25. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013; 14: 1086. Go to original source...
    26. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 81: 59. Go to original source...
    27. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580. Go to original source... Go to PubMed...
    28. Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 2015; 373: 307. Go to original source...
    29. Poortmans PM, Collette S, Kirkove C, et al. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. N Engl J Med 2015; 373: 317. Go to original source...
    30. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305: 569. Go to original source... Go to PubMed...
    31. Giuliano AE, Hunt K, Ballman KV, et al. Ten-year survival results of ACOSOB Z0011: A randomized trial of axillary nodal dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node (Alliance). J Clin Oncol 34, 2016 (suppl; abstr 1007). Go to original source...
    32. Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013; 14: 297. Go to original source...
    33. Thorsen LB, Offersen BV, Dan? H, et al. DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol 2016; 34: 314. Go to original source...
    34. Chang JS, Park W, Kim YB, et al. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 2013; 86: 867. Go to original source...
    35. Hennequin C, Bossard N, Servagi-Vernat S, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 2013; 86: 860. Go to original source...
    36. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003; 95: 1205-1211. Go to original source... Go to PubMed...
    37. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004; 60: 722-730. Go to original source...
    38. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996; 32A: 608-611. Go to original source... Go to PubMed...
    39. Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016; 387: 229. Go to original source...
    40. Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg. 2003; 138: 1253-1256. Go to original source... Go to PubMed...
    41. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010; 376: 91-102. Go to original source...
    42. Vicini FA, Chen P, Wallace M, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007; 69: 1124-1130. Go to original source...
    43. National Surgical Adjuvant Breast and Bowel Project (NASBP)/Radiation Therapy Oncology Group (RTOG). A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer. NSABP Protocol B-39/RTOG Protocol 0413. Philadelphia, PA: NASBP/RTOG; 2007.
    44. Bentzen SM, Yarnold JR. Reports of unexpected late side effects of accelerated partial breast irradiation-radiobiological considerations. Int J Radiat Oncol Biol Phys. 2010; 77: 969-973. Go to original source... Go to PubMed...
    45. Valachis A, Mauri D, Polyzos NP, et al. Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J 2010; 16: 245. Go to original source... Go to PubMed...
    46. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 2015; 51: 451. Go to original source... Go to PubMed...
    47. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009; 74: 987. Go to original source... Go to PubMed...
    48. Arthur DW, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2003; 2: 124. Go to original source... Go to PubMed...
    49. Wilder RB, Curcio LD, Khanijou RK, et al. Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Int J Radiat Oncol Biol Phys 2010; 78: 799. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.